Position papers

Filter results for:

 
April 2008
25/04/2008

EuropaBio comments related to “Labelling of food enzymes, additives and flavourings produced by Genetically Modified Micro-organisms (GMM)”

documents : EN  
08/04/2008
Submission to the EU Public Consultation on a Legal Proposal on Information to Patients
documents : EN  
March 2008
24/03/2008
European Patent Litigation reform - the question of exclusivity
documents : EN  
February 2008
14/02/2008
Farm Animals say yes to Low Level Presence of GM
documents : EN  
14/02/2008
Joint EBE-EuropaBio Postition Paper European Commission Public Consultation Rare Diseases: Europe’s Challenges
documents : EN
11/02/2008
Submission of comments on the European Commission’s strategy to better protect health by strengthening and rationalising EU pharmacovigilance
documents : EN
January 2008
21/01/2008
EuropaBio publishes comments on the development of environmental sustainability criteria for biofuels
documents : EN
14/01/2008
Letter of support sent by the Chair of the Healthcare Council to EUnetHTA in response to its proposal for collaboration with stakeholders 2009+
documents : EN
04/01/2008

EuropaBio submission to the European Commission Public Consultation on the comitology part of the revision of the Variations Regulations

documents : EN
October 2007
12/10/2007

Consultation on the Future of Pharmaceuticals for Human Use in Europe 

documents : EN
01/10/2007

Contribution Of the European Taskforce on Bioterrorism to the Green Paper on Bio-Preparedness   

documents : EN
August 2007
24/08/2007
EMEA Paediatric Network
documents : EN
 
17/08/2007
Biofuels in Europe EuropaBio position and specific recommendations
documents : EN
 
July 2007
13/07/2007
Management of low level presence of GM products approved outside the EU and present in traded commodities entering the EU 
documents : EN
WTO Ruling on Biotech Products 
documents : EN
 
June 2007
29/06/2007

Comments on draft report on current practices with regard to the provision of information to patients on medicinal products

documents : EN
May 2007
04/05/2007

High-Level Pharmaceutical Forum Public Consultation on Health-Related Information to Patients

documents : EN
 
March 2007
26/03/2007
Adventitious presence - Bringing clarity to confusion
documents : EN
Key messages on adventitious presence in seed
documents : EN

EuropaBio Contributions to the Consultation of the DG Enterprise and Industry Project on Distribution Channels

documents: EN
 
February 2007
12/02/2007

Discussion Document for a Health Strategy

documents : EN
January 2007
31/01/2007

Consultation Regarding Community Action on Health Services

documents : EN
December 2006
20/12/2006

EuropaBio key response to the European Commission consultation paper regarding: better regulation of pharmaceuticals towards simpler, clearer and more flexible framework of variations

documents : EN
November 2006
10/11/2006

EuropaBio Position Paper on  Naming and Labelling Requirements for Biosimilar Medicines

documents : EN
02/11/2006
EuropaBio Position on the Proposal package for legislation on food additives, flavouring and enzymes
documents : EN

 

September 2006
27/09/2006

EuropaBio contribution to the Pharmaceutical Forum on Information to Patients

documents : EN
27/09/2006

EuropaBio contribution to the Pharmaceutical Forum on Relative Effectiveness

documents : EN
27/09/2006

EuropaBio contribution to the Pharmaceutical Forum on Pricing

documents : EN
 
August 2006

EuropaBio position paper: Review of Directive 86/609 on the Protection of Animals Used for Experimental and Other Scientific Purposes

documents : EN
 
April 2006
06/04/2006

The EU’s approval process for biotechnology derived crops
Letter addressed to Mr. José Manuel Barroso, President of the European Commission

documents : EN
 
March 2006
23/03/2006

EuropaBio Position on the Reform of the EU Sugar Regime, adopted by the EU Agricultural Ministers (20 February 2006)

documents : EN
10/03/2006

EuropaBio principles for accessing genetic resources 

documents : EN
 
October 2005
30/10/2005

EuropaBio Position paper on Draft Guideline on Similar Biological Medicinal Products Containing Biotechnology-Derived Proteins As Active Substance: Non-Clinical and Clinical Issues ref. EMEA/CHMP/42832/2005 - Released for consultation in May 2005

documents : EN
September 2005
22/09/2005
  Patients need innovative medicines, says Manifesto
Healthcare Manifesto special website:
http://www.healthcare-manifesto.org
documents : EN
July 2005
27/07/2005

EuropaBio Position paper on the Reform of the EU sugar regime

documents : EN
 
June 2005
27/06/2005
 

EuropaBio Position paper on the proposal for a Community Regulatory Framework on Advanced Therapies of 04 May 2005
- Official text - Comparisons
- Official text - Modified

documents : EN
13/06/2005
 

The European Biotechnology Industry View on the proposed Regulation on Medicinal Products for Paediatric Use. (Joint common position)

documents : EN
01/06/2005
EuropaBio Position paper: The scope of the EU GM Food & Feed Regulation (EC) 1829/2003
documents : EN
April 2005
22/04/2005
 

EuropaBio comments on the proposal for a Regulation on medicinal products for paediatric use.

documents : EN
March 2005
04/03/2005
 

EBE and EuropaBio White Paper - “Towards an optimal Orphan Medicinal Products (OMP) Framework in Europe”

documents : EN
29/03/2005
 

EuropaBio and Eucomed paper "Why human cell & tissue-engineered products (hTEPs) need a specific and separate Regulation".

documents : EN
February 2005
01/02/2005
Framework Programme for Competitiveness and Innovation.
documents : EN
01/02/2005
  EuropaBio Position paper: Coexistence of GM crops with non-GM crops is possible in the EU.
documents : EN
January 2005
31/01/2005
  Consultation Response - The application of the Lamfalussy process to EU securities markets legislation.
documents : EN
 
28/02/2005
  EuropaBio position on the EMEA Guideline on Similar biological medicinal products (ref. EMEA/CHMP/437/04).
documents : EN
December 2004
22/12/2004
  Comments from EuropaBio on the draft Regulation on the conditional marketing authorisation for medicinal products.
documents : EN
08/12/2004
  "Commission Consultation Paper" - Provisions for micro, small and medium-size enterprises (SMEs), establishing the circumstances in which SMEs may pay reduced fees, defer payment of the fee, or receive administrative assistance.
documents : EN
October 2004
01/10/2004
  Joint industry comments on Draft Technical Requirements for tissues and cells Response Form.
documents : EN
September 2004
15/09/2004
  EuropaBio comments on WHO-Priority medicine project.
documents : EN
August 2004
13/08/2004
  Joint comments on proposal for a harmonised regulatory framework on human tissue engineered products: DG Enterprise consultation paper.
documents : EN  (annex available here)
19/08/2004
  Joint industry position on the draft Commission Proposal for a Council Regulation on the fees payable to the European Medicines Agency, replacing existing Council Regulation (EC) No 297/95.
documents : EN
June 2004
30/06/2004
  EuropaBio contribution to the European Medicines Agency Road Map to 2010: preparing the ground for the future.
documents : EN
May 2004
01/05/2004
Human Medical Genetic Testing. A EuropaBio Position Paper
documents : EN
April 2004
29/04/2004
  EuropaBio Feedback on Commission’s Consultation Paper on Tissue Engineered Products Legislation
documents : EN
  EuropaBio position paper on Draft Commission Decision (EC) No…/.. establishing minimum thresholds for adventitious
documents : EN
February 2004
10/02/2004
Brussels Day report (14th - 15th October 2003)
documents : EN
06/02/2004
  EuropaBio Position Paper on PROPOSED TECHNOLOGY TRANSFER BLOCK EXEMPTION REGULATION AND GUIDELINES
documents : EN
December 2003
22/12/2003
EuropaBio position paper on Human Medical Genetic Testing (December 2003)
documents : EN
19/12/2003
What is the Young Innovative Company (YIC) status?
documents : EN
November 2003
27/11/2003
  The Position of the Plant Biotechnology Unit on the Graefe zu Baringdorf Draft Report
The Graefe zu Baringdorf  Draft Report on
“Coexistence between genetically modified crops and conventional and organic crops” :  2003/2098(INI)
documents : EN
  EuropaBio position paper on Proposed Directive on Environmental Liability
Proposed Directive on Environmental Liability
Legal Affairs Ctee vote, 2nd December 2003
documents : EN
26/11/2003
 

EuropaBio position paper on draft technology transfer regulation
EuropaBio Position Paper on:
the draft Commission Regulation (EC) on the application of Article 81 (3) of the Treaty to categories of technology transfer agreements,
the draft Guidelines on the application of Article 81 of the EC Treaty to technology transfer agreements.

documents : EN
14/11/2003
  Human stem cell research: a novel technology that will benefit patients - information and position paper
documents : EN
13/11/2003
 

Comments on CX/FICS 03 /4- “Discussion Paper on Traceability/Product Tracing in the Context of Food Import and Export Inspection and Certification Systems”

documents : EN
October 2003
01/10/2003
 

EuropaBio position paper on the definition of generic medicinal products as developed in the common position on the revision of Directive 2001/83/EC on the Community Code for Human Medicines

documents : EN | FR | DE
  EuropaBio position on biosimilar medicinal products as regulated in the common position on the revision of Directive 2001/83/EC on the community code for human medicines
documents : EN | FR | DE
  EuropaBio (revised) position paper on Council common position of DG Sanco Directive (October 2003)
documents : EN
July 2003
14/07/2003
Coexistence of GM crops with Non GM crops in the EU
documents : EN
11/07/2003
  How to boost innovation and research in Europe?
A EuropaBio proposal to the EU Competitiveness Council of Ministers, Rome, 11-12 July 2003
documents : EN
June 2003
02/06/2003
Environmental Liability - position paper following 1st Reading
documents : EN
01/06/2003
Food Feed & Traceability Labelling - position paper on centralised procedure
documents : EN
Food Feed & Traceability Labelling - position paper on coexistence
documents : EN
Food Feed & Traceability Labelling - position paper on pre-approved events
documents : EN
Food Feed & Traceability Labelling- position paper on GMOs labelling threshold
documents : EN
May 2003
28/05/2003
CODEX - Europabio position on Animal Feeding
documents : EN
13/05/2003
DG Enterprise - Tissue engineering - Industry letter to Commissioner Liikanen
documents : EN
12/05/2003
Environmental Liability - EuropaBio letter on GMOs
documents : EN
07/05/2003
Environmental Liability - industry joint position paper
documents : EN
April 2003
15/04/2003
CODEX - EuropaBio position on Food Labeling
documents : EN
01/04/2003
CODEX - EuropaBio position on Risk Assessment for Food Safety paper
documents : EN
February 2003
20/02/2003
Emerging Enterprises Board Priorities for 2003
documents : EN
06/02/2003
  EuropaBio comments on EMEA annex for "guidance on comparability containing biotech-derived proteins as drug substances" Ref. CPMP/3097/02
documents : EN
January 2003
14/01/2003
Questions and Answers on Environmental Liability
documents : EN | FR
13/01/2003
Clean, sustainable and white....
documents : EN
November 2002
21/11/2002
EuropaBio position on Environmental Liability Proposal
documents : EN
September 2002
30/09/2002
  Need for a legislative framework for human tissue engineering and tissue-engineered products
documents : EN
30/09/2002
 

Second Entry of Biotechnological Medicinal Products - Remark to Members of the European Parliament Committee on the Environment, Public Health and Consumer Policy - Pharmaceutical Review Directive

documents : EN
October 2001
23/10/2001
  Key Issues raised in the Commission’s proposal for a Regulation concerning Traceability and Labelling of GMOs
documents : EN
08/10/2001
  Plant Biotechnology Unit Comments on the Commission Proposal for a Regulation concerning Genetically Modified Food and Feed
documents : EN
June 2001
23/06/2001
GMO Fact Sheet
documents : EN
13/06/2000
Information paper on ethical, social and public awareness issues in gene therapy.
documents : EN
March 2000
06/03/2000
  Assuring Consumer Confidence in the Safety of Biotechnology and Food Products.
Comments on the Commission Proposal to Establish a Food Safety Authority.
A Paper by the Plant Biotechnology Unit of EuropaBio
documents : EN
February 2000
22/02/2000
  Development and Regulatory Aspects of the Use of Xenogeneic Cells :A EuropaBio Position Paper
documents : EN
01/02/2000
 

Benefits of genetically modified crops : Scientists confirm reduction of pesticide use
The Associated Press reports on a recent Iowa State University study which shows that farmers in the Mid West of the United States, who planted Bt (genetically modified, GM) corn (maize) from 1996 to 1998, succeeded in reducing their insecticide use each year.
Bt maize is genetically engineered to produce a protein that is toxic to some insects, including the European corn borer. The insects die after feeding on GM maize leaves and stalks.

documents : EN
December 1999
03/12/1999
 

Discussion Paper on the Precautionary Principle
The precautionary principle is an element of international environmental law . EuropaBio, the European Association of BioIndustries, is aware that the European Commission is currently working on a communication on this principle, in the context of risk management. To further the current discussions, EuropaBio would like to identify a number of fundamental points listed hereunder.

documents : EN
October 1999
22/10/1999
Biotechnology companies welcome EU-agreement on threshold for G.M.labelling
documents : EN
10/10/1999
Why the article in nature magazine on ‘substantial equivalence ’ is irrelevant
documents : EN
April 1999
15/04/1999
  Biotechnology Industry Channeling Program helps US farmers to sell novel trait corn crops which have not yet obtained EU import clearance.
documents : EN
February 1999
19/02/1999
Stringent safety tests in place for genetically modified foods
documents : EN
January 1999
25/01/1999
 

UK House of Lords Second Report on the EU regulation of biotechnology in Agriculture - An important contribution to the discussion on effective EU regulation

documents : EN
 
 
Homepage  |   Contact  |   EuropaBio Team © 2000-2008   |  EuropaBio  aisbl - VAT BE 477.520.310